Project aims

  • Aim 1: Identification of interictal biomarkers for episodic and chronic migraine
  • Aim 2: Identification of genetic risk factors and pathways for episodic and chronic
  • Aim 3: Identification of biomarkers and understanding the mechanisms predicting migraine attacks
  • Aim 4: Understanding major nociceptive mechanisms relevant to migraine
  • Aim 5: Investigating the efficacy and mode of action pharmacological treatments
  • Aim 6: Development of novel neuromodulation devices and stimulation protocols